Voloridge Investment Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
AC
Voloridge Investment Management's KYNB Position: Q3 2023 in Review
Voloridge Investment Management sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 3,375 shares — an estimated $228K sold.
Voloridge Investment Management first reported a position in KYNB in Q3 2017 and held it in 12 quarters. The position peaked at $8.4M in Q3 2021. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.
- Voloridge Investment Management reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
- Voloridge Investment Management sold 3,375 Kyntra Bio shares in Q3 2023, an estimated $228K.
- Voloridge Investment Management first reported a position in Kyntra Bio in Q3 2017 and held it in 12 quarters.
- Voloridge Investment Management's Kyntra Bio position peaked at $8.4M in Q3 2021.
- 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.
Based on Voloridge Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.